ArticleFrontiers in public health2025
Prevalence and genotype assessment of HPV in 73,697 females from Beijing, China.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Genetic Variation of HPV53 and the Identification of T-Cell Epitopes.Microorganisms · 2026Article
- An epidemiological survey of HPV infection among women in Southern Hebei, China.Virology journal · 2026Article
- From HPV genotypes to cervical lesion burden: public health-relevant heterogeneity across 1.29 million screening records in Guangdong, China.Frontiers in public health · 2026Article
- Prevalence and genotype distribution of human papillomavirus infection among women undergoing HPV testing at a hospital in Zhangzhou, China: a retrospective study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The present study aimed to assess the prevalence and genotype distribution of Human papillomavirus (HPV) in Beijing females. Methods: A total of 73,697 subjects [both Department of Gynecology ( Results: An overall HPV infection rate of 17.28% (12,736/73,697) over the past decade (2014 to 2023), with a significant decrease in annual incidence ( Conclusion: This study emphasizes the importance of HPV infection rate from real word and developing vaccines specifically for the Chinese population. In the future, it is necessary to design more suitable vaccines based on Chinese HPV type ranking, especially for HR-HPV (HPV-39, HPV-53, and HPV-56) and LR-HPV (HPV-43, HPV-61, and HPV-81).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.